Literature DB >> 25403520

Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity.

Carlos Cuevas1, Sandro Huenchuguala, Patricia Muñoz, Monica Villa, Irmgard Paris, Bengt Mannervik, Juan Segura-Aguilar.   

Abstract

U373MG cells are able to take up aminochrome that induces glutathione transferase M2-2 (GSTM2) expression in a concentration-dependent manner where 100 µM aminochrome increases GSTM2 expression by 2.1-fold (P < 0.001) at 3 h. The uptake of (3)H-aminochrome into U373MG cells was significantly reduced in the presence of 2 µM nomifensine (P < 0.001) 100 µM imipramine (P < 0.001) and 50 mM dopamine (P < 0.001). Interestingly, U373MG cells excrete GSTM2 into the conditioned medium and the excretion was significantly increased (2.7-fold; P < 0.001) when the cells were pretreated with 50 µM aminochrome for 3 h. The U373MG-conditioned medium containing GSTM2 protects SH-SY5Y cells incubated with 10 µM aminochrome. The significant protection provided by U373MG-conditioned medium in SH-SY5Y cells incubated with aminochrome was dependent on GSTM2 internalization into SH-SY5Y cells as evidenced by (i) uptake of (14)C-GSTM2 released from U373MG cells into SH-SY5Y cells, a process inhibited by anti-GSTM2 antiserum; (ii) lack of protection of U373MG-conditioned medium in the presence of anti-GSTM2 antiserum on SH-SY5Y cells treated with aminochrome; and (iii) lack of protection of conditioned medium from U373MGsiGST6 that expresses an siRNA directed against GSTM2 on SH-SY5Y cells treated with aminochrome. In conclusion, our results demonstrated that U373MG cells protect SH-SY5Y cells against aminochrome neurotoxicity by releasing GSTM2 into the conditioned medium and subsequent internalization of GSTM2 into SH-SY5Y cells. These results suggest a new mechanism of protection of dopaminergic neurons mediated by astrocytes by releasing GSTM2 into the intersynaptic space and subsequent internalization into dopaminergic neuron in order to protect these cells against aminochrome neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25403520     DOI: 10.1007/s12640-014-9500-1

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  51 in total

1.  Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome.

Authors:  Mireille Lafon-Cazal; Oumeya Adjali; Nathalie Galéotti; Joël Poncet; Patrick Jouin; Vincent Homburger; Joël Bockaert; Philippe Marin
Journal:  J Biol Chem       Date:  2003-04-22       Impact factor: 5.157

Review 2.  Energy substrates to support glutamatergic and GABAergic synaptic function: role of glycogen, glucose and lactate.

Authors:  Arne Schousboe; Lasse K Bak; Helle M Sickmann; Ursula Sonnewald; Helle S Waagepetersen
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

3.  Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease.

Authors:  F C Cheng; J S Kuo; L G Chia; G Dryhurst
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease.

Authors:  W Linert; E Herlinger; R F Jameson; E Kienzl; K Jellinger; M B Youdim
Journal:  Biochim Biophys Acta       Date:  1996-08-23

5.  Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes.

Authors:  S Baez; J Segura-Aguilar; M Widersten; A S Johansson; B Mannervik
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

6.  Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine.

Authors:  Mossa Gardaneh; Mostafa Gholami; Nader Maghsoudi
Journal:  Rejuvenation Res       Date:  2011-01-11       Impact factor: 4.663

7.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

8.  On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase.

Authors:  J Segura-Aguilar; C Lind
Journal:  Chem Biol Interact       Date:  1989       Impact factor: 5.192

9.  Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction.

Authors:  Sandro Huenchuguala; Patricia Muñoz; Patricio Zavala; Mónica Villa; Carlos Cuevas; Ulises Ahumada; Rebecca Graumann; Beston F Nore; Eduardo Couve; Bengt Mannervik; Irmgard Paris; Juan Segura-Aguilar
Journal:  Autophagy       Date:  2014-01-14       Impact factor: 16.016

10.  Astroglial dopamine transport is mediated by norepinephrine transporter.

Authors:  Hiroshi Takeda; Masato Inazu; Teruhiko Matsumiya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2002-09-25       Impact factor: 3.000

View more
  18 in total

Review 1.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

2.  Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-01-29       Impact factor: 3.911

3.  Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease.

Authors:  David Sulzer; Fabio A Zucca; Luigi Zecca
Journal:  Clin Pharmacol Transl Med       Date:  2019-05-06

4.  Novel Alpha-Synuclein Oligomers Formed with the Aminochrome-Glutathione Conjugate Are Not Neurotoxic.

Authors:  Sandro Huenchuguala; Birgitta Sjödin; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-10-20       Impact factor: 3.911

Review 5.  Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Authors:  Fabio A Zucca; Juan Segura-Aguilar; Emanuele Ferrari; Patricia Muñoz; Irmgard Paris; David Sulzer; Tadeusz Sarna; Luigi Casella; Luigi Zecca
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

6.  Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson's disease.

Authors:  Andrea Herrera; Patricia Muñoz; Irmgard Paris; Gabriela Díaz-Veliz; Sergio Mora; Jose Inzunza; Kjell Hultenby; Cesar Cardenas; Fabián Jaña; Rita Raisman-Vozari; Katia Gysling; Jorge Abarca; Harry W M Steinbusch; Juan Segura-Aguilar
Journal:  Cell Mol Life Sci       Date:  2016-03-21       Impact factor: 9.261

7.  Aminochrome Toxicity is Mediated by Inhibition of Microtubules Polymerization Through the Formation of Adducts with Tubulin.

Authors:  Andrea Briceño; Patricia Muñoz; Patricia Brito; Sandro Huenchuguala; Juan Segura-Aguilar; Irmgard B Paris
Journal:  Neurotox Res       Date:  2015-09-07       Impact factor: 3.911

8.  Cellular Trafficking of Glutathione Transferase M2-2 Between U373MG and SHSY-S7 Cells is Mediated by Exosomes.

Authors:  Raúl Valdes; Alicia Armijo; Patricia Muñoz; Kjell Hultenby; Andres Hagg; Jose Inzunza; Ivan Nalvarte; Mukesh Varshney; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2021-02-08       Impact factor: 3.911

9.  A new mechanism for protection of dopaminergic neurons mediated by astrocytes.

Authors:  Juan Segura-Aguilar
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

10.  Commentary: Evaluation of Models of Parkinson's Disease.

Authors:  Patricia Muñoz; Irmgard Paris; Juan Segura-Aguilar
Journal:  Front Neurosci       Date:  2016-04-19       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.